Cannabinoid 2 receptor is a novel anti-inflammatory target in experimental proliferative vitreoretinopathy.

@article{Szczesniak2017Cannabinoid2R,
  title={Cannabinoid 2 receptor is a novel anti-inflammatory target in experimental proliferative vitreoretinopathy.},
  author={Anna-Maria Szczesniak and Richard F Porter and James Toguri and Joanna Borowska-Fielding and Simon Gebremeskel and Anuja Siwakoti and B. Lynn Johnston and Christian Lehmann and Melanie E. M. Kelly},
  journal={Neuropharmacology},
  year={2017},
  volume={113 Pt B},
  pages={627-638}
}
Proliferative vitreoretinopathy (PVR) can develop after ocular trauma or inflammation and is a common complication of surgery to correct retinal detachment. Currently, there are no pharmacological treatments for PVR. Cannabinoids acting at cannabinoid 2 receptor (CB2R) can decrease inflammation and fibrosis. The objective of this study was to examine the… CONTINUE READING